Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The document concludes that mesotherapy can be effective for skin and hair treatments, but more research is needed to confirm its safety and effectiveness.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

New treatments for a type of skin cancer show promise but have side effects and may work better with other therapies.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

Triple therapy with clobetasol, hydroxychloroquine, and N-acetylcysteine is recommended for better outcomes in treating lichen planopilaris.

Use the least toxic, most specific treatments for skin diseases, considering side effects and individual patient needs.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

The document suggests a personalized treatment plan for alopecia areata based on the patient's age and hair loss severity, using a range of therapies ranked by effectiveness and safety.

No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.

Multiple treatments work best for hair loss.

Topical immunotherapy is still effective for managing alopecia areata, even with new treatments available.

Insurers opposed ASCO's recommendation for a single cancer care pathway program.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

New treatments for severe alopecia areata show promise but lack standard approval.

imTA and pulse therapy are effective for alopecia areata with manageable side effects, but relapse rates need improvement.

Barbara prefers natural remedies but is advised against certain supplements and mistakenly links her cancer and hair loss to unrelated causes.

Psychotropic drugs can help treat skin conditions affected by mental health, but dermatologists must use them carefully due to side effects and patient concerns.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

Hormonal therapies can improve skin issues by adjusting hormone levels, with future advancements promising better results.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

Biologic agents are effective for severe hidradenitis suppurativa when other treatments fail.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Two people lost hair unexpectedly after getting a common hair loss treatment with a drug called Dutasteride.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

Combination therapies work better than single treatments for hair loss.